Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Hepato-Gastroenterology|December 5, 1998
Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liverC Loinaz, F Colina, M Musella, et al.Clinical and Experimental Dermatology|May 30, 1998
Lichen myxoedematosus associated with human immunodeficiency virus infection--report of two cases and review of the literatureJ D Domínguez Auñon, C Postigo Llorente, R Llamas Martin, et al.Oncogene|September 6, 2006
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancerJ Carretero, P P Medina, R Blanco, et al.The Journal of Pathology|November 10, 2007
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplificationB Angulo, A Suarez-Gauthier, F Lopez-Rios, et al.British Journal of Cancer|June 21, 2012
A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimensD Gonzalez de Castro, B Angulo, B Gomez, et al.Journal for Immunotherapy of Cancer|January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitorsAristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.ESMO Open|May 13, 2021
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapyA Bamias, A S Merseburger, Y Loriot, et al.British Journal of Cancer|August 3, 2013
Stromal disrupting effects of nab-paclitaxel in pancreatic cancerR Alvarez, M Musteanu, E Garcia-Garcia, et al.ESMO Open|July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners FoundationS Peters, M-L Meyer, F André, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)M Aldea, M Salto-Tellez, A Marra, et al.Pageof 1